secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2026-09-14T20:33:11+00:00
Accession:  0001093557-26-000175
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom promotes CFO Jereme Sylvain to COO; he retains CFO role effective Sept 14, 2026
--------------------------------------------------------------------------------

- Jereme Sylvain appointed EVP, COO and CFO, effective 9/14/2026, adding oversight of global operations and quality teams.
- New annual base salary of $767,000 with target bonus of 75% of base; remains eligible for annual equity awards.
- Sylvain joined Dexcom in 2018, has served as CFO since 2021; CEO Jake Leach cited operational discipline and customer focus.
- No family relationships or material interests with Dexcom directors/officers disclosed under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000175/0001093557-26-000175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000175/dxcm-20260910.htm
  HTML page:      https://secwatch.observer/filing/0001093557-26-000175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer